VANCOUVER, BC — Kardium Inc., a private medical device company that has developed the Globe® System for the treatment of atrial fibrillation (AF), announced positive results of the 1-year outcomes of the… Read More
Under a new agreement, GlycoNet and NOVA FCT will leverage their combined expertise in the study of carbohydrates for knowledge exchange, collaborative research and training opportunities. EDMONTON, AB – GlycoNet, one of the world’s leaders in glycomics, has signed a… Read More
Prince George celebrated a significant milestone in early 2024 with the opening of a new clinical trial called CIRCULATE-NORTH-AMERICA, or CRC10, which marked the first time a systemic therapy clinical… Read More
Montreal, QC — Amplitude Ventures, a full-stack venture capital firm focused on investing in precision medicine at the intersection of biology and AI, announced the close of its $263 million… Read More
VANCOUVER, BC – Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, announced data presentations highlighting azetukalner (XEN1101) clinical data in major depressive disorder (MDD) at the American Society of Clinical… Read More
